Xeris Biopharma Holdings, Inc. Quarterly Operating Leases, Future Minimum Payments Due in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Leases, Future Minimum Payments Due history and growth rate from Q3 2021 to Q3 2022.
  • Xeris Biopharma Holdings, Inc. Operating Leases, Future Minimum Payments Due for the quarter ending September 30, 2022 was $77.4M, a 255% increase year-over-year.
Operating Leases, Future Minimum Payments Due, Quarterly (USD)
Operating Leases, Future Minimum Payments Due, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $77.4M +$55.6M +255% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $20.7M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $21.2M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $21.5M Dec 31, 2021 10-K 2023-03-08
Q3 2021 $21.8M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.